FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
-9.7%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$11.4B
AUM Growth
+$11.4B
(-20%)
Cap. Flow
-$846M
Cap. Flow
% of AUM
-7.42%
Top 10 Holdings %
Top 10 Hldgs %
47.34%
Holding
116
New
12
Increased
50
Reduced
18
Closed
19
Top Buys
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
$547M |
| 2 |
RHT
Red Hat Inc
RHT
|
$472M |
| 3 |
AABA
Altaba Inc. Common Stock
AABA
|
$369M |
| 4 |
Cigna
CI
|
$200M |
| 5 |
Equinix
EQIX
|
$177M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$1.51B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$1.13B |
| 3 |
COL
Rockwell Collins
COL
|
$584M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$257M |
| 5 |
BPYU
Brookfield Property REIT Inc. Class A Common Stock
BPYU
|
$169M |
Sector Composition
| 1 | Communication Services | 28.35% |
| 2 | Healthcare | 24.1% |
| 3 | Technology | 21.57% |
| 4 | Industrials | 8.78% |
| 5 | Consumer Discretionary | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
51
DELISTED
Sage Therapeutics
SAGE
| $38.3M | 0.28% | 400,000 -225,000 | -36% | -$21.6M |
|
52
CRISPR Therapeutics
CRSP
$4.71B
| $35.7M | 0.26% | 1,250,000 +231,406 | +23% | +$6.61M |
|
53
FibroGen
FGEN
$47.8M
| $34.7M | 0.25% | 750,000 -645,000 | -46% | -$29.9M |
|
|
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
| $33.7M | 0.25% | 2,043,149 | – | – |
|
|
BPY
55
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $33.4M | 0.25% | 2,075,000 +1,280,618 | +161% | +$20.6M |
|
|
RC
56
Ready Capital
RC
$700M
| $30.5M | 0.22% | 2,203,239 | – | – |
|
|
ORBK
57
DELISTED
Orbotech Ltd
ORBK
| $30.3M | 0.22% | 535,721 +305,721 | +133% | +$17.3M |
|
58
Fate Therapeutics
FATE
$120M
| $28.2M | 0.21% | 2,200,000 +1,670,000 | +315% | +$21.4M |
|
59
PTC Therapeutics
PTCT
$3.92B
| $24M | 0.18% | 700,000 +280,000 | +67% | +$9.61M |
|
60
Zymeworks
ZYME
$1.12B
| $23.1M | 0.17% | 1,575,000 +240,000 | +18% | +$3.52M |
|
61
Codexis
CDXS
$246M
| $19.3M | 0.14% | 1,155,000 +155,000 | +16% | +$2.59M |
|
62
Arrowhead Research
ARWR
$3.05B
| $18.6M | 0.14% | +1,500,000 | New | +$18.6M |
|
63
Savara
SVRA
$567M
| $18.4M | 0.13% | 2,425,000 +6,991 | +0.3% | +$52.9K |
|
64
Dynavax Technologies
DVAX
$1.19B
| $18.3M | 0.13% | 2,000,000 +930,000 | +87% | +$8.51M |
|
65
AB InBev
BUD
$122B
| $18.2M | 0.13% | 275,843 -17,266 | -6% | -$1.14M |
|
|
CLVS
66
DELISTED
Clovis Oncology, Inc.
CLVS
| $18M | 0.13% | +1,000,000 | New | +$18M |
|
|
PGNX
67
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $17.6M | 0.13% | 4,200,820 +588,000 | +16% | +$2.47M |
|
|
CCXI
68
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.8M | 0.12% | 1,450,000 +300,000 | +26% | +$3.27M |
|
|
SHPG
69
DELISTED
Shire pic
SHPG
| $15.2M | 0.11% | 87,000 | – | – |
|
70
Protagonist Therapeutics
PTGX
$3.67B
| $14.8M | 0.11% | 2,199,674 -43,528 | -2% | -$293K |
|
|
QTNT
71
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $14.7M | 0.11% | +2,400,000 | New | +$14.7M |
|
|
BMS
72
DELISTED
Bemis
BMS
| $14.5M | 0.11% | 316,160 +109,500 | +53% | +$5.03M |
|
|
ILPT
73
Industrial Logistics Properties Trust
ILPT
$409M
| $12M | 0.09% | +610,545 | New | +$12M |
|
|
APTX
74
DELISTED
Aptinyx Inc. Common Stock
APTX
| $11.1M | 0.08% | 670,000 | – | – |
|
|
TECX
75
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $10.8M | 0.08% | 650,000 +185,000 | +40% | +$3.08M |
|